JP2001527567A - フルルビプロフェン舐剤を製造する方法 - Google Patents

フルルビプロフェン舐剤を製造する方法

Info

Publication number
JP2001527567A
JP2001527567A JP54999298A JP54999298A JP2001527567A JP 2001527567 A JP2001527567 A JP 2001527567A JP 54999298 A JP54999298 A JP 54999298A JP 54999298 A JP54999298 A JP 54999298A JP 2001527567 A JP2001527567 A JP 2001527567A
Authority
JP
Japan
Prior art keywords
composition
flurbiprofen
forming
lozenge
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP54999298A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001527567A5 (enExample
Inventor
デイ、アンドリュー
ジョーンズ、フー、リン
スミス、カール、サイモン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JP2001527567A publication Critical patent/JP2001527567A/ja
Publication of JP2001527567A5 publication Critical patent/JP2001527567A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP54999298A 1997-05-22 1998-05-20 フルルビプロフェン舐剤を製造する方法 Ceased JP2001527567A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
GB9710521.7 1997-05-22
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
JP2001527567A true JP2001527567A (ja) 2001-12-25
JP2001527567A5 JP2001527567A5 (enExample) 2005-12-08

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54999298A Ceased JP2001527567A (ja) 1997-05-22 1998-05-20 フルルビプロフェン舐剤を製造する方法

Country Status (31)

Country Link
US (1) US6194003B1 (enExample)
EP (1) EP0983059B1 (enExample)
JP (1) JP2001527567A (enExample)
KR (1) KR20010012739A (enExample)
CN (1) CN1154480C (enExample)
AR (1) AR015812A1 (enExample)
AT (1) ATE245021T1 (enExample)
AU (1) AU725760B2 (enExample)
BG (1) BG103881A (enExample)
BR (1) BR9809651A (enExample)
CA (1) CA2290830C (enExample)
CZ (1) CZ290816B6 (enExample)
DE (1) DE69816440T2 (enExample)
DK (1) DK0983059T3 (enExample)
ES (1) ES2202871T3 (enExample)
GB (1) GB9710521D0 (enExample)
HU (1) HU224954B1 (enExample)
ID (1) ID22949A (enExample)
IL (1) IL132999A0 (enExample)
IN (1) IN187837B (enExample)
MY (1) MY118410A (enExample)
NO (1) NO995681D0 (enExample)
NZ (1) NZ500664A (enExample)
PL (1) PL190947B1 (enExample)
PT (1) PT983059E (enExample)
RU (1) RU2203046C2 (enExample)
SK (1) SK283701B6 (enExample)
TR (1) TR199902725T2 (enExample)
UA (1) UA53714C2 (enExample)
WO (1) WO1998052539A1 (enExample)
ZA (1) ZA984260B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012500786A (ja) * 2008-08-22 2012-01-12 レキット ベンキサー ヘルスケア （ユーケイ） リミテッド 組成物における改良又は組成物に関連した改良
WO2017029710A1 (ja) * 2015-08-18 2017-02-23 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124124B2 (en) 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2644400C (en) 2005-02-03 2014-04-08 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
BRPI0809430A2 (pt) * 2007-07-23 2014-09-09 Teikoku Pharma Usa Inc Formulações de dosagem oral, organolepticamente aceitáveis, de um agonista indol do receptor de cerotonina e métodos de utilização das mesmas
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
EP2701681B1 (en) 2011-04-29 2016-10-19 Moberg Pharma AB Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012500786A (ja) * 2008-08-22 2012-01-12 レキット ベンキサー ヘルスケア （ユーケイ） リミテッド 組成物における改良又は組成物に関連した改良
WO2017029710A1 (ja) * 2015-08-18 2017-02-23 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物

Also Published As

Publication number Publication date
SK158899A3 (en) 2000-05-16
AU7916598A (en) 1998-12-11
HU224954B1 (en) 2006-04-28
WO1998052539A1 (en) 1998-11-26
ID22949A (id) 1999-12-16
ATE245021T1 (de) 2003-08-15
MY118410A (en) 2004-10-30
DE69816440D1 (de) 2003-08-21
EP0983059B1 (en) 2003-07-16
TR199902725T2 (xx) 2000-02-21
DK0983059T3 (da) 2003-11-03
GB9710521D0 (en) 1997-07-16
HUP0002121A3 (en) 2001-04-28
IL132999A0 (en) 2001-03-19
AU725760B2 (en) 2000-10-19
KR20010012739A (ko) 2001-02-26
NO995681L (no) 1999-11-19
EP0983059A1 (en) 2000-03-08
NO995681D0 (no) 1999-11-19
ZA984260B (en) 1999-02-20
DE69816440T2 (de) 2004-05-13
CA2290830A1 (en) 1998-11-26
CN1255848A (zh) 2000-06-07
BG103881A (bg) 2000-05-31
BR9809651A (pt) 2000-07-11
NZ500664A (en) 2001-01-26
PT983059E (pt) 2003-11-28
AR015812A1 (es) 2001-05-30
RU2203046C2 (ru) 2003-04-27
UA53714C2 (uk) 2003-02-17
PL190947B1 (pl) 2006-02-28
CA2290830C (en) 2006-07-11
ES2202871T3 (es) 2004-04-01
CZ412099A3 (cs) 2000-02-16
CN1154480C (zh) 2004-06-23
US6194003B1 (en) 2001-02-27
SK283701B6 (sk) 2003-12-02
HUP0002121A2 (hu) 2000-12-28
IN187837B (enExample) 2002-06-29
CZ290816B6 (cs) 2002-10-16
PL336624A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
US6194003B1 (en) Process for making flurbiprofen lozenges
RU2203655C2 (ru) Средство и способ облегчения симптомов больного горла
US5922347A (en) Pharmaceutical chewing gum containing acetylsalicylic acid
US7078053B2 (en) Ibuprofen composition
KR20030074810A (ko) 성 기능장애의 치료를 위한 신속-발현 약
WO1998052545A1 (en) Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO1998052540A1 (en) Pharmaceutical compositions
JP2005526120A (ja) 口腔咽頭の空洞障害の局所治療用ジクロフェナク系組成物
JPH10203963A (ja) 殺菌性物質と粘膜付着性物質を含む口内投与用医薬品組成物
JP7751354B1 (ja) 結晶の製造方法
JP7688467B1 (ja) 結晶の製造方法
MXPA99010548A (en) Process for making flurbiprofen lozenges
JP2026049835A (ja) 固形組成物
JP2026047053A (ja) 固形組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050511

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050511

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090420

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090608

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090810

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090915